Department of Laboratory Medicine, Third Xiangya Hospital, Central South University, Changsha, Hunan, 410013, China.
Department of Pharmacy, Third Xiangya Hospital, Central South University, Changsha, Hunan, 410013, China.
J Stroke Cerebrovasc Dis. 2024 Dec;33(12):108019. doi: 10.1016/j.jstrokecerebrovasdis.2024.108019. Epub 2024 Sep 18.
Previous observational studies have suggested that thyroid function may be associated with functional outcome after ischemic stroke (IS). Nevertheless, the causal relationship remains unclear. This study aimed to explore the causal effect of thyroid function [thyroid-stimulating hormone (TSH), free thyroxine (FT4), hyperthyroidism, and hypothyroidism] on functional outcome (based on the modified Rankin scale) after IS by two-sample Mendelian randomization (MR) analysis.
Inverse variance weighted (IVW) was the primary method for evaluating causal associations. In addition, six additional MR methods (MR-Egger regression, weighted median, maximum likelihood, simple mode, weighted mode, and MR-PRESSO) were employed to supplement IVW. Furthermore, various sensitivity tests were conducted to assess the reliability: (i) Cochrane's Q test for assessing heterogeneity; (ii) MR-Egger intercept test and MR-PRESSO global test for evaluating horizontal pleiotropy; (iii) leave-one-out sensitivity test for determining stability.
The results of IVW indicated that elevated TSH levels significantly improved functional outcome after IS (OR = 0.74, 95 % CI: 0.57-0.97, P = 0.028). In addition, six additional MR methods suggested parallel results. However, no causal effect of FT4, hyperthyroidism, and hypothyroidism on functional outcome after IS was identified. In addition, sensitivity tests demonstrated the reliability of the MR analyses, suggesting that the MR analysis was not influenced by significant heterogeneity and horizontal pleiotropy.
Our MR study supported that elevated TSH levels might improve functional outcome after IS. Therefore, regular monitoring and maintenance of stable TSH levels may benefit patients recovering from IS.
先前的观察性研究表明,甲状腺功能可能与缺血性脑卒中(IS)后的功能结局有关。然而,因果关系仍不清楚。本研究旨在通过两样本 Mendelian 随机化(MR)分析探讨甲状腺功能[促甲状腺激素(TSH)、游离甲状腺素(FT4)、甲状腺功能亢进和甲状腺功能减退]与 IS 后功能结局(基于改良 Rankin 量表)的因果关系。
反向方差加权(IVW)是评估因果关系的主要方法。此外,还采用了六种额外的 MR 方法(MR-Egger 回归、加权中位数、最大似然、简单模式、加权模式和 MR-PRESSO)来补充 IVW。此外,还进行了各种敏感性测试来评估可靠性:(i)Cochrane's Q 检验评估异质性;(ii)MR-Egger 截距检验和 MR-PRESSO 全局检验评估水平偏倚;(iii)逐一剔除敏感性测试确定稳定性。
IVW 的结果表明,升高的 TSH 水平显著改善 IS 后的功能结局(OR = 0.74,95%CI:0.57-0.97,P = 0.028)。此外,六种额外的 MR 方法也表明了平行的结果。然而,FT4、甲状腺功能亢进和甲状腺功能减退对 IS 后功能结局没有因果影响。此外,敏感性测试表明了 MR 分析的可靠性,表明 MR 分析不受显著异质性和水平偏倚的影响。
我们的 MR 研究支持升高的 TSH 水平可能改善 IS 后的功能结局。因此,定期监测和维持稳定的 TSH 水平可能有益于 IS 后恢复的患者。